Paul Silva - Vertex Pharmaceuticals Insider

VRTX -- USA Stock  

USD 151.69  3.33  2.15%

Senior Vice President Corporate Controller

Mr. Paul M. Silva is Senior Vice President and Corporationrationrate Controller of Vertex Pharmaceuticals Incorporated. Mr. Silva is our Senior Vice President and Corporationrationrate Controller, a position he has held since April 2011. Mr. Silva joined us in August 2007 as Senior Director, Accounting Operations and was our Vice President and Corporationrationrate Controller from September 2008 through April 2011. Prior to joining us, he was the Vice President, Internal Reporting at Iron Mountain Incorporated from July 2006 until August 2007 and a consultant to Iron Mountains financing department from April 2005 until July 2006. He was the Finance Director of the Bioscience Technologies Division of Thermo Electron Corporationrationration from 2002 to April 2005
Age: 50  President Since 2011      
Silva holds a B.S. in accounting from Assumption College.

Paul Silva Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 7.26 % which means that it generated profit of $7.26 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 3.37 % meaning that it created $3.37 on every $100 dollars invested by stockholders.
The company currently holds 595.12 M in liabilities with Debt to Equity (D/E) ratio of 24.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.61 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Francis CussBristol Myers Squibb Company
Michael HolstonMerck Co
Barton PetersonEli Lilly and Company
Richard DeLucaMerck Co
Annette TumoloBio Rad Laboratories
Willie DeeseMerck Co
Alfonso ZuluetaEli Lilly and Company
Joseph CaldarellaBristol Myers Squibb Company
Christi ShawEli Lilly and Company
Jaime ContrerasAbbott Laboratories
Wayne SwantonAllergan plc
Joshua SmileyEli Lilly and Company
Michael RousseauAbbott Laboratories
Daniel SalvadoriAbbott Laboratories
Carrie NicholEndo International plc
Louis SchmuklerBristol Myers Squibb Company
Johna NortonEli Lilly and Company
Deepak NathAbbott Laboratories
Hugh ONeillMallinckrodt Public Limited Com
Jonathon KellermanAllergan plc
Darren CarrollEli Lilly and Company

Entity Summary

Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ. It employs 2300 people.Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 2,300 people. Vertex Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Vertex Pharmaceuticals Leadership Team

Paul Silva, President
William Young, Director, MBA
David Altshuler, Director
Reshma Kewalramani, President
Jeffrey Chodakewitz, President
Elaine Ullian, Director
Michael Parini, President
Alan Garber, Director, Ph.D
Amit Sachdev, President
Joshua Boger, Chairman
David Greenway, Director
Bruce Sachs, Director, MBA
Margaret McGlynn, Director, MBA
Michael Partridge, President
Yuchun Lee, Director, MBA
Sangeeta Bhatia, Director, Ph.D
Kimberly White, President
Stuart Arbuckle, EVP
Thomas Graney, President, MBA
Terrence Kearney, Director, MBA
Ian Smith, President
Jeffrey Leiden, Chairman, Ph.D

Stock Performance Indicators

Current Sentiment - VRTX

Vertex Pharmaceuticals Investor Sentiment
Most of Macroaxis users are at this time bullish on Vertex Pharmaceuticals Incorporated. What is your outlook on investing in Vertex Pharmaceuticals Incorporated? Are you bullish or bearish?
98% Bullish
2% Bearish
Also Currentnly Active
Purchased over 100 shares of
few days ago
Traded for 10.44
Purchased over 300 shares of
few days ago
Traded for 6.24
Purchased over 70 shares of
few days ago
Traded for 23.42
Also please take a look at World Market Map. Please also try CEO Directory module to screen ceos from public companies around the world.